{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:37:22Z","timestamp":1790717842485,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jmoldx.2024.09.003","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T04:09:33Z","timestamp":1732507773000},"page":"1159-1170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism"],"prefix":"10.1016","volume":"26","author":[{"given":"Ruoheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3770-4143","authenticated-orcid":false,"given":"Yimeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cioccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7441-9531","authenticated-orcid":false,"given":"Kevin","family":"Rakszawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5480-2517","authenticated-orcid":false,"given":"Myles","family":"Nickolich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"Rybka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Mierski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Silar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-2138","authenticated-orcid":false,"given":"Valerie","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Claxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5289-331X","authenticated-orcid":false,"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-7080","authenticated-orcid":false,"given":"Shin","family":"Mineishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Shike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2024.09.003_bib1","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/bmt.2014.2","volume":"49","author":"Solomon","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41408-021-00519-y","article-title":"Mixed T cell lineage chimerism in acute leukemia\/MDS using pre-emptive donor lymphocyte infusion strategy-is it prognostic?-a single-center retrospective study","volume":"11","author":"Sheth","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib4","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00277-021-04616-7","article-title":"Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion","volume":"100","author":"Shah","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100997","article-title":"The mythological chimera and new era of relapse prediction post-transplant","volume":"57","author":"Ciurea","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood-2017-09-801498","article-title":"Minimal\/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party","volume":"131","author":"Schuurhuis","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/bmt.2016.167","article-title":"Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies: a review from the ALWP of the EBMT","volume":"51","author":"Tsirigotis","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib8","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2016-06-724500","article-title":"Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel","volume":"129","author":"de Witte","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3324\/haematol.2012.062638","article-title":"Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia","volume":"97","author":"Nazha","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2012.317","article-title":"Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1\/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia","volume":"27","author":"Wakita","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.2019004770","article-title":"Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia","volume":"135","author":"Hasserjian","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/bmt.2014.254","article-title":"Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia","volume":"50","author":"Jacque","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13549","article-title":"Highly sensitive chimerism detection in blood is associated with increased risk of relapse after allogeneic hematopoietic cell transplantation in childhood leukemia","volume":"23","author":"Haugaard","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib14","article-title":"Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: digital PCR versus quantitative real-time PCR of insertion\/deletion polymorphisms","volume":"14","author":"Valero-Garcia","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41375-019-0624-4","article-title":"Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation","volume":"34","author":"Bouvier","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3324\/haematol.2019.238543","article-title":"Quantitative PCR-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study","volume":"106","author":"Gambacorta","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib17","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41409-020-0801-0","article-title":"Monitoring minimal residual\/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia","volume":"55","author":"Wethmar","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bjh.13073","volume":"168","author":"Clark","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib19","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1182\/blood.V99.12.4618","article-title":"Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction","volume":"99","author":"Alizadeh","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.leu.2403622","article-title":"Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion\/deletion polymorphisms","volume":"19","author":"Jimenez-Velasco","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jmoldx.2014.06.005","article-title":"Chimerism monitoring after allogeneic hematopoietic stem cell transplantation using quantitative real-time PCR of biallelic insertion\/deletion polymorphisms","volume":"16","author":"Kim","year":"2014","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jmoldx.2019.01.007","article-title":"Personalized chimerism test: selection of short tandem repeat or quantitative PCR depending on patient's chimerism status","volume":"21","author":"Tyler","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib23","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1705582","article-title":"Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia","volume":"39","author":"Huisman","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bmt.1704444","article-title":"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective","volume":"33","author":"Bader","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib28","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1200\/JCO.2004.05.198","article-title":"Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?","volume":"22","author":"Bader","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41409-022-01615-8","article-title":"Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"57","author":"Lindahl","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmoldx.2024.01.007","article-title":"Engraftment and measurable residual disease monitoring after hematopoietic stem cell transplantation: comparison of two chimerism test strategies, next-generation sequencing versus a combination of short-tandem repeats and quantitative PCR","volume":"26","author":"Zhang","year":"2024","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.110794","article-title":"Assessment of chimerism by next generation sequencing: a comparison to STR\/qPCR methods","volume":"85","author":"Brow","year":"2024","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2019.01.011","article-title":"Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Yuda","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2008.07.002","article-title":"Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Oshima","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib34","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1080\/10428194.2021.1929966","article-title":"Donor derived leukemia in allogeneic transplantation","volume":"62","author":"Aldoss","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bbmt.2008.07.013","article-title":"Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen","volume":"14","author":"Saito","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib36","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.bbmt.2015.07.005","article-title":"Mixed T lymphocyte chimerism after allogeneic hematopoietic transplantation is predictive for relapse of acute myeloid leukemia and myelodysplastic syndromes","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbmt.2014.08.018","article-title":"Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults","volume":"21","author":"Peterlin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib38","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbmt.2017.07.007","volume":"23","author":"Caldemeyer","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1200\/JCO.20.02308","article-title":"Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia","volume":"39","author":"Craddock","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbmt.2015.09.004","article-title":"Tolerability and clinical activity of post-transplantation azacitidine in patients allografted for acute myeloid leukemia treated on the RICAZA trial","volume":"22","author":"Craddock","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib41","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.19.03277","article-title":"Effect of rhG-CSF combined with decitabine prophylaxis on relapse of patients with high-risk MRD-negative AML after HSCT: an open-label, multicenter, randomized controlled trial","volume":"38","author":"Gao","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib42","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.3324\/haematol.2018.211615","article-title":"Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT acute leukemia working party","volume":"104","author":"Bazarbachi","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.2002.20.2.405","article-title":"Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation","volume":"20","author":"Levine","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.09.003_bib44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/ejh.12168","volume":"91","author":"Yan","year":"2013","journal-title":"Eur J Haematol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824002125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824002125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:15:32Z","timestamp":1764555332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157824002125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525157824002125"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.09.003","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}